MedPath

The efficacy of preoperative single dose intravenous dexamethasone in decreasing the postparotidectomy facial nerve dysfunction rate in patients with benign superficial lobe of parotid tumor

Not Applicable
Conditions
Facial nerve dysfunction.
Injury of facial nerve
Registration Number
IRCT2016060823594N2
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

patients with benign parotid tumor and normal facial nerve function
Exclusion criteria: patients with history of diabetes mellitus; history of autoimmune diseases; sensitivity to corticosteroids and other contraindications of these medicines; history of corticosteroid use; tumor spread to deep lobe; history of previous surgery of the parotid; history of face and neck radiotherapy; history of malignant disease in parotid gland and face; and preoperative facial nerve dysfunction in each branch

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Facial nerve dysfunction. Timepoint: First day, one week and one month after the surgery. Method of measurement: Physical exam.
Secondary Outcome Measures
NameTimeMethod
Involved branches of facial nerve. Timepoint: First day, one week and one month after the surgery. Method of measurement: Physical exam.;Size of tumor. Timepoint: After surgery. Method of measurement: Lab.;Histologic type of tumor. Timepoint: After surgery. Method of measurement: Lab.;Position of tumor. Timepoint: During surgery. Method of measurement: Visual.
© Copyright 2025. All Rights Reserved by MedPath